Abstract
Implantable electrophysiology is enjoying another breakthrough in devices designed for the treatment of ventricular tachycardia or primary and secondary prevention of sudden cardiac death. The EHRA/HRS/LAHRS/APHRS opinion published in Europace presents the practical comment, indications and perspectives for implantable wireless devices. Most of the implantable device problems have concerned venous access for cardiac leads. In response to the demand of patients for whom such access is impossible in the last decade, modern CEIDs with electrodes outside the vascular system or completely leadless systems have been introduced [1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
